Skip to content

Clinical trials

Hepatitis B, Chronic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Country / region: China Clear all

357 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20024
20032
20043
20054
20063
20074
200810
200911
201013
201111
201210
201314
20149
201516
201620
201715
201815
201913
202029
202124
202224
202328
202433
202523
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131
Unknown status125
Recruiting51
Active, not recruiting20
Not yet recruiting16
Terminated11
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Ditan Hospital27
Third Affiliated Hospital, Sun Yat-Sen University24
Nanfang Hospital, Southern Medical University18
Hoffmann-La Roche16
GlaxoSmithKline13
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.12
Ausper Biopharma Co., Ltd.11
Beijing 302 Hospital10
Huashan Hospital10
The Second Affiliated Hospital of Chongqing Medical University8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic357
Hepatitis B54
Carcinoma, Hepatocellular11
Liver Cirrhosis11
Fibrosis9
Hepatitis8
Non-alcoholic Fatty Liver Disease7
Hepatitis, Chronic5
Acute-On-Chronic Liver Failure4
Fatty Liver3

Trials

Showing 76 to 100 of 357. Each trial links to its page on Pharma Observatory.

257 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.